Medical Condition News

RSS

New oral drug appears to offer hope for fighting indolent non-Hodgkin lymphoma

Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time.

22 Jan 2014

Adverse events for patients treated for heart attack and heart failure have declined, study finds

Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.

22 Jan 2014

Lack of SIRT1 protein in the liver leads to lower levels of liver FGF21

A new study led by Boston University School of Medicine demonstrates that the abnormal metabolism linked to obesity could be regulated in part by the interaction of two metabolic regulators, called the NAD-dependent deacetylase SIRT1 and fibroblast growth factor 21 (FGF21). Using experimental models, the researchers found that a lack of SIRT1 protein in the liver led to lower levels of a liver secreted protein FGF21, which resulted in an increased likelihood of developing fatty liver disease and obesity.

22 Jan 2014

High-protein diet increases chance of developing kidney stones, other renal diseases

High-protein diets, like the popular Dr. Dukan diet, increase the long-term risk of developing kidney disease and have a negative effect on renal urinary and morphological markers. What's more, they may promote serious pathologies like nephrolithiasis (calcium kidney stones) because they drastically reduce urinary citrate (an inhibitor of calcium salt crystallization) and urinary pH, and increase urinary calcium (to compensate for the metabolic acidity caused by excess protein).

22 Jan 2014

Research under way to develop new techniques for detecting diabetic retinopathy

Research is under way to develop new techniques for detecting diabetic retinopathy at early onset with the hope of improving prevention and treatment of this major cause of blindness.

22 Jan 2014

EnVivo Pharmaceuticals starts encenicline Phase 3 study in patients with Alzheimer's disease

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.

22 Jan 2014

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Advanced melanoma affects around 2,000 people per year in the UK. Advanced melanoma describes a melanoma that has spread from its site of origin to other areas of the body.

22 Jan 2014

Long-term exposure to particulate matter linked with increased risk for heart attack

Long-term exposure to particulate matter is associated with an increased risk for heart attack. Moreover, this association can already be observed in levels of particulate exposure below the current specified European limit values.

22 Jan 2014

Study reports that being overweight makes children less active

A new study from the University of Copenhagen's OPUS Research Centre reports that being overweight makes children less active. The findings underscore that parents of overweight children have an obligation to keep their children active, as physical activity is vital for the general health of all children. The study also shows that slender children do not become overweight due to a lack of activity.

22 Jan 2014

Girls treated for Hodgkin's disease during adolescence acquire risk of developing breast cancer

Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ärzteblatt International.

22 Jan 2014

Researchers assess familial risks for MS using population registers, health care registries

Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, published in the scientific journal Brain.

22 Jan 2014

EKF Diagnostics announces major breakthrough for PointMan DNA enrichment technology

EKF, announces a major breakthrough for its PointMan DNA enrichment technology for potential use in future cancer testing and treatment.

From EKF Diagnostics 22 Jan 2014

Joint research program in SMA enters initial stage of clinical development

PTC Therapeutics, Inc., the SMA Foundation, and Roche, announced today that their joint research program in Spinal Muscular Atrophy has entered the first stage of clinical development aiming to assess safety and tolerability of an oral compound in healthy volunteers.

22 Jan 2014

Increasing number of children are treated in U.S. EDs for head injuries

Although a voluntary shopping cart safety standard was implemented in the United States in 2004, the overall number and rate of injuries to children associated with shopping carts have not decreased. In fact, the number and rate of concussions/closed head injuries have continued to climb, according to a new study.

22 Jan 2014

Self-testing for HPV effective in detecting cervical cancer

Self-testing for Human Papillomavirus (HPV) - the virus that causes cervical cancer - is as effective at detecting cancer as a conventional smear test (cytology screening) even when scaled up to test large populations.

22 Jan 2014

CytRx receives FDA approval to continue dosing aldoxorubicin for patients with soft tissue sarcomas

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to continue dosing patients with aldoxorubicin until disease progression in a planned pivotal, global Phase 3 clinical trial with aldoxorubicin as a second-line treatment for soft tissue sarcomas.

22 Jan 2014

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.

22 Jan 2014

Strategic placement of care managers in PCMHs can improve outcomes for high-risk diabetes patients

Patient centered medical homes (PCMHs) have been found to be an effective way to help care for patients with chronic diseases such as diabetes. Dr. Robert Gabbay, M.D., Ph.D., FACP, Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and his team conducted a study that shows the strategic placement of care managers in PCMHs can further improve patient outcomes for high-risk diabetes patients.

22 Jan 2014

New orthotic device could aid in rehabilitation of patients with ankle-foot disorders

A soft, wearable device that mimics the muscles, tendons and ligaments of the lower leg could aid in the rehabilitation of patients with ankle-foot disorders such as drop foot, said Yong-Lae Park, an assistant professor of robotics at Carnegie Mellon University.

22 Jan 2014

ASA's recommendations to help patients avoid unnecessary tests for chronic pain

Not prescribing opioids first or as a long-term therapy for chronic, non-cancer pain and avoiding MRIs, CTs and X-rays for low-back pain are among the tests and treatments identified by ASA that are commonly ordered but not always necessary.

22 Jan 2014

Medical Condition News

New oral drug appears to offer hope for fighting indolent non-Hodgkin lymphoma

Adverse events for patients treated for heart attack and heart failure have declined, study finds

Lack of SIRT1 protein in the liver leads to lower levels of liver FGF21

High-protein diet increases chance of developing kidney stones, other renal diseases

Research under way to develop new techniques for detecting diabetic retinopathy

EnVivo Pharmaceuticals starts encenicline Phase 3 study in patients with Alzheimer's disease

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Long-term exposure to particulate matter linked with increased risk for heart attack

Study reports that being overweight makes children less active

Girls treated for Hodgkin's disease during adolescence acquire risk of developing breast cancer

Researchers assess familial risks for MS using population registers, health care registries

EKF Diagnostics announces major breakthrough for PointMan DNA enrichment technology

Joint research program in SMA enters initial stage of clinical development

Increasing number of children are treated in U.S. EDs for head injuries

Self-testing for HPV effective in detecting cervical cancer

CytRx receives FDA approval to continue dosing aldoxorubicin for patients with soft tissue sarcomas

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Strategic placement of care managers in PCMHs can improve outcomes for high-risk diabetes patients

New orthotic device could aid in rehabilitation of patients with ankle-foot disorders

ASA's recommendations to help patients avoid unnecessary tests for chronic pain

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News